SCHEDULE: Wellington Management Discloses 4.1% Stake in Disc Medicine

Wellington Management Group and its affiliates reported a 4.1% beneficial ownership stake in Disc Medicine, Inc. as of June 30, 2025, holding 1,432,090 common shares.

Summary

• Wellington Management Group LLP, Wellington Group Holdings LLP, and Wellington Investment Advisors Holdings LLP collectively reported beneficial ownership of 1,432,090 shares of Disc Medicine, Inc. common stock.
• This represents 4.1% of Disc Medicine, Inc.'s common stock outstanding.
• The filing is an Amendment No. 1 to a Schedule 13G, updating a previously filed statement.
• The shares are held in the ordinary course of business and were not acquired for the purpose of changing or influencing control of Disc Medicine, Inc.

Sentiment

Score: 7

Explanation: The filing indicates a significant institutional investor, Wellington Management, maintains a substantial stake in Disc Medicine, Inc., suggesting continued confidence in the company's long-term prospects without any activist intentions. This is a neutral to slightly positive signal.

Positives

• A major institutional investor, Wellington Management, maintains a significant stake in Disc Medicine, Inc., indicating continued confidence in the company.
• The ownership is for passive investment purposes, not for activist intentions, which suggests stability in the shareholder base.

Risks

• No company-specific operational or financial risks are detailed in this beneficial ownership filing, as its purpose is solely to report ownership.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Disc Medicine, Inc.'s future performance or strategic direction.

Industry Context

The continued significant holding by Wellington Management, a prominent global asset manager, in Disc Medicine, Inc. reflects ongoing institutional interest in the biotechnology or pharmaceutical sector, where Disc Medicine likely operates given its name.

Stakeholder Impact

• Shareholders: Provides transparency on significant institutional ownership, potentially signaling stability or confidence in the company's stock.
• Management: Awareness of a large, passive institutional holder in the company's stock.

Key Dates

Recommendation

This Schedule 13G filing primarily discloses beneficial ownership by Wellington Management Group and its affiliates. While the significant stake held by a reputable institutional investor like Wellington Management can be seen as a positive signal of confidence, the filing itself does not contain financial performance data, strategic updates, or forward-looking guidance that would warrant a 'buy' or 'sell' recommendation. The ownership is stated to be for ordinary course investment purposes, not for control influence. Therefore, a 'hold' recommendation is appropriate as this filing provides transparency on ownership but no new fundamental information to alter an investment thesis.

Keywords

Disc Medicine, Wellington Management, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Institutional Investment